These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 31783698)
21. Protective effects of tocotrienols against lipid-induced nephropathy in experimental type-2 diabetic rats by modulation in TGF-β expression. Siddiqui S; Ahsan H; Khan MR; Siddiqui WA Toxicol Appl Pharmacol; 2013 Dec; 273(2):314-24. PubMed ID: 24041758 [TBL] [Abstract][Full Text] [Related]
22. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells. Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056 [TBL] [Abstract][Full Text] [Related]
23. Dendritic cell vaccine modified by Ag85A gene enhances anti-tumor immunity against bladder cancer. Zhang P; Wang J; Wang D; Wang H; Shan F; Chen L; Hou Y; Wang E; Lu CL Int Immunopharmacol; 2012 Nov; 14(3):252-60. PubMed ID: 22884511 [TBL] [Abstract][Full Text] [Related]
24. Enhancement of antitumor immunity of dendritic cells pulsed with heat-treated tumor lysate in murine pancreatic cancer. Kim HS; Choo YS; Koo T; Bang S; Oh TY; Wen J; Song SY Immunol Lett; 2006 Mar; 103(2):142-8. PubMed ID: 16313973 [TBL] [Abstract][Full Text] [Related]
25. [Investigation on specific killing acute leukemia cell reaction of the cytotoxic T lymphocyte induced by dendritic cell pulsed with frozen-thawed antigen]. He B; Qiu G; Xie X Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Dec; 21(6):974-8. PubMed ID: 15646345 [TBL] [Abstract][Full Text] [Related]
27. Dendritic cell-tumor coculturing vaccine can induce antitumor immunity through both NK and CTL interaction. Kim KD; Choi SC; Kim A; Choe YK; Choe IS; Lim JS Int Immunopharmacol; 2001 Nov; 1(12):2117-29. PubMed ID: 11710541 [TBL] [Abstract][Full Text] [Related]
28. A randomized controlled trial of postoperative tumor lysate-pulsed dendritic cells and cytokine-induced killer cells immunotherapy in patients with localized and locally advanced renal cell carcinoma. Zhan HL; Gao X; Pu XY; Li W; Li ZJ; Zhou XF; Qiu JG Chin Med J (Engl); 2012 Nov; 125(21):3771-7. PubMed ID: 23106871 [TBL] [Abstract][Full Text] [Related]
29. Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status. Nesaretnam K; Stephen R; Dils R; Darbre P Lipids; 1998 May; 33(5):461-9. PubMed ID: 9625593 [TBL] [Abstract][Full Text] [Related]
30. CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice. Jadidi-Niaragh F; Atyabi F; Rastegari A; Kheshtchin N; Arab S; Hassannia H; Ajami M; Mirsanei Z; Habibi S; Masoumi F; Noorbakhsh F; Shokri F; Hadjati J J Control Release; 2017 Jan; 246():46-59. PubMed ID: 27993599 [TBL] [Abstract][Full Text] [Related]
31. The immunotherapeutic effect of dendritic cells vaccine modified with interleukin-18 gene and tumor cell lysate on mice with pancreatic carcinoma. Tang ZH; Qiu WH; Wu GS; Yang XP; Zou SQ; Qiu FZ World J Gastroenterol; 2002 Oct; 8(5):908-12. PubMed ID: 12378640 [TBL] [Abstract][Full Text] [Related]
32. [Anti-tumor effect of cisplatin combined with DC vaccine on tumor-bearing mice]. You HY; Lian WG; Zhang HL; Wang JX; Zhang KX; Song SX Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):336-40. PubMed ID: 22883452 [TBL] [Abstract][Full Text] [Related]
33. Expression of a soluble TGF-beta receptor by tumor cells enhances dendritic cell/tumor fusion vaccine efficacy. Zhang M; Berndt BE; Chen JJ; Kao JY J Immunol; 2008 Sep; 181(5):3690-7. PubMed ID: 18714045 [TBL] [Abstract][Full Text] [Related]
34. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb. Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374 [TBL] [Abstract][Full Text] [Related]
35. [Study on the specific immunity induced by dendritic cell vaccine loading allogenic microvascular endothelial cell bEnd.3 antigen against U14 cervical cancer cell in mice]. Zhao J; Lu J; Liu YQ; Yang HY; Huang YT; Zhao JM; Li S; Zhai JM; Zhao MY; Zhang X; Dong ZM Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):52-7. PubMed ID: 21429436 [TBL] [Abstract][Full Text] [Related]
37. [Immunotherapeutic effects of beta-elemene combined with interleukin-23 gene-modified dendritic cells on murine pancreatic carcinoma]. Tan G; Wang ZY; Wang XG; Cheng L; Yin S Ai Zheng; 2006 Sep; 25(9):1082-6. PubMed ID: 16965646 [TBL] [Abstract][Full Text] [Related]
38. Tumor regression after systemic administration of tocotrienol entrapped in tumor-targeted vesicles. Fu JY; Blatchford DR; Tetley L; Dufès C J Control Release; 2009 Dec; 140(2):95-9. PubMed ID: 19709637 [TBL] [Abstract][Full Text] [Related]
40. Cancer immunotherapy using in vitro genetically modified targeted dendritic cells. Wei H; Wang H; Lu B; Li B; Hou S; Qian W; Fan K; Dai J; Zhao J; Guo Y Cancer Res; 2008 May; 68(10):3854-62. PubMed ID: 18483270 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]